Point72 Hong Kong’s Orthofix Medical OFIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-381
Closed -$12K – 2277
2022
Q1
$12K Buy
+381
New +$12.2K ﹤0.01% 1582
2021
Q4
– Sell
-498
Closed -$19K – 2239
2021
Q3
$19K Buy
+498
New +$19.8K ﹤0.01% 1714
2021
Q2
– Sell
-834
Closed -$36K – 2231
2021
Q1
$36K Buy
834
+303
+57% +$13.4K ﹤0.01% 1348
2020
Q4
$23K Buy
531
+227
+75% +$8.29K ﹤0.01% 1394
2020
Q3
$9K Sell
304
-785
-72% -$24.3K ﹤0.01% 1006
2020
Q2
$35K Sell
1,089
-738
-40% -$24.5K ﹤0.01% 796
2020
Q1
$51K Buy
1,827
+1,270
+228% +$49.1K 0.02% 346
2019
Q4
$26K Buy
557
+396
+246% +$18.6K 0.01% 833
2019
Q3
$9K Buy
161
+60
+59% +$3.1K ﹤0.01% 770
2019
Q2
$5K Buy
+101
New +$5.37K ﹤0.01% 932
2019
Q1
– Sell
-52
Closed -$3K – 1205
2018
Q4
$3K Buy
+52
New +$2.96K ﹤0.01% 701

Other funds holding OFIX

Point72 Hong Kong's OFIX Position: Q2 2022 in Review

Point72 Hong Kong sold out of Orthofix Medical (OFIX) in Q2 2022, closing a stake of 381 shares — an estimated $12K sold.

Point72 Hong Kong first reported a position in OFIX in Q4 2018 and held it in 11 quarters. The position peaked at $51K in Q1 2020. 130 funds tracked by Wall St. Rank hold OFIX as of Q2 2022.

  • Point72 Hong Kong reported no remaining Orthofix Medical position as of Q2 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 381 Orthofix Medical shares in Q2 2022, an estimated $12K.
  • Point72 Hong Kong first reported a position in Orthofix Medical in Q4 2018 and held it in 11 quarters.
  • Point72 Hong Kong's Orthofix Medical position peaked at $51K in Q1 2020.
  • 130 funds tracked by Wall St. Rank held Orthofix Medical as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.